Barda grants. Aug 5, 2025 · HHS announced the beginning of a coordinated wind-down of its...

Barda grants. Aug 5, 2025 · HHS announced the beginning of a coordinated wind-down of its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority. Jun 14, 2021 · Home About HHS Agencies Organizational Chart ASPR Biomedical Advanced Research and Development Authority (BARDA) Navigate to:. Academic innovators and companies developing technologies aimed at improving health security for pediatric and special populations are eligible to apply. S. We offer funding for research and development, proof-of-concept projects, and acceleration partnerships that improve preparedness and response. We offer funding for research and development, proof-of-concept projects, and acceleration partnerships that improve preparedness and response. To-date, BARDA has supported 42 FDA approvals for products addressing CBRN, PI, and EID threats. BARDA has a proven track record of using supplemental funding to respond to emerging infectious disease outbreaks. Proposals should align with BARDA’s mission and focus on innovative solutions in specified technology areas. Proposals submitted in response to the BARDA Broad Agency Announcement (BAA) must focus on research and development activities that relate to specific areas of interest, consisting of medical countermeasures for chemical, biological, radiological, and nuclear threats; pandemic influenza and emerging infectious diseases. In addition, through our DRIVe Accelerator Network, we will have teams forward deployed throughout the USA to identify promising solutions wherever innovation is happening. In the tables below, we describe BARDA funding awards to date. ABOUT BARDA The mission of the Biomedical Advanced Research and Development Authority (BARDA) is to develop medical countermeasures that address the public health and medical consequences of chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases. Development, Evaluation, and Validation Services The Network provides funding to startups to evaluate and validate novel medical countermeasures that align with BARDA's strategic priorities. Jul 5, 2020 · The Biomedical Advanced Research and Development Authority (BARDA), a division of the Department of Health and Human Services, is one of the federal entities leading this effort. BARDA’s support includes funding, technical assistance and core services, ranging from a clinical research organization network to Centers for Innovation in Advanced Development and Manufacturing, and a fill-finish manufacturing network. Its mission is to prepare for and respond to public health emergencies, protecting the public against pandemic influenza (the flu), emerging infectious diseases (EID), and chemical, biological, radiological, a Strategic Proposal Development: Craft comprehensive and compelling submissions that align with BARDA’s mission. DRIVe will leverage new authorities given to BARDA under the 21st Century Cures Act to stimulate innovation through both non-dilutive funding and dilutive funding. In response to the Zika outbreak, BARDA provided support for the only FDA-cleared point-of-care diagnostic. Last updated November 2 Jul 18, 2023 · This guide aims to help you through the application process, financial requirements, and technical requirements for BARDA funding. PARTNER WITH DRIV e DRIV e partners with innovators across industry, academia, non-profit, and government to accelerate innovation and enhance the nation's health security. The Biomedical Advanced Research and Development Authority, or BARDA, is an agency of the U. These include awards for research, development, manufacturing, and procurement. If you or your company are developing a medical countermeasure or platform technology to combat chemical, biological, radiological, or nuclear threats, pandemic influenza or other emerging infectious diseases, consider doing business with BARDA. Department of Health and Human Services(HHS). BARDA’s Broad Agency Announcement (BAA) sets forth the advanced research and development Areas of Interest (AOIs) and solicits proposals focusing on these areas in order to protect the United States against public health emergency threats. Financial Planning: Develop detailed budgets and sustainability strategies that enhance your proposal’s competitiveness. Explore how you can work with us: See Partnering Opportunities BARDA’s Broad Agency Announcement (BAA) solicits proposals for the advanced research and development of medical countermeasures (MCMs) such as vaccines, therapeutics, diagnostics, and devices. Discover how BARDA strengthens preparedness and response to combat health security threats through advanced research, development of vaccine, therapies, and diagnostic tools for biological, chemical, and nuclear emergencies. pxg vrr ydo hvq erf ycd sio txc njb tce qbc bzb gfx ayz usp